Dr. Daniel Pascheles, Merck & Co.
Dr. Daniel Pascheles, Vice President, Head Global Competitive Intelligence, Merck & Co.
Dr. Daniel R. Pascheles is Head, Global Competitive Intelligence, and is based in Whitehouse Station NJ, at the Global HQ of Merck & Co., Inc.
His responsibilities include providing intelligence regarding business, research and development activities of competitors, as well as participating in, and contribution to the strategy development process, the target identification for licensing and M&A activities.
Pascheles joined Merck & Co., Inc. early 2005 from Aventis Inc. where he was Vice President and head of Corporate Competitive Intelligence. He has worked for Aventis and its predecessor company (Hoechst Marion Roussel, Marion Merrell Dow) for 14 years in various positions and locations.
Pascheles studied Pharmacy at the Swiss Federal Institute of Technology in Zurich, Switzerland. He received his Ph.D. in Pharmaceutical Technology from the same university. He has done additional study at the University of Kansas in Lawrence, Kansas.
Pascheles is Past-President and current Board member of the Pharmaceutical Business Intelligence & Research Group (PBIRG). He is also member of the Society of Competitive Intelligence Professionals (SCIP) and the Licensing Executive Society (LES).
Sue Ward, Pfizer
Sue Ward, Senior Director, Worldwide Competitive Intelligence, Pfizer
Sue Ward is currently Senior Director of Worldwide Competitive Intelligence within Pfizer’s Corporate Strategic Planning group. Previously within Pfizer, Sue led the competitive intelligence team within Information & Knowledge Management. Prior to joining Pfizer, Sue worked in the UK as Associate Director of Competitive Analysis for SmithKline Beecham (SB)(now GSK). Other positions held by Sue within SB included managing a Clinical Information group and the Product Literature Information Service. Sue now holds a BSc (Hons) in Biology from University College London and an MSc in Information Science from The City University, London.